⌘K

Login Start Free

Home/Filings/4/0001144204-14-073255

4//SEC Filing

PHARMATHENE, INC 4

Accession 0001144204-14-073255

$ALTCIK 0001326190operating

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 9:03 PM ET

Size

5.5 KB

Accession

0001144204-14-073255

Insider Transaction Report

Form 4

Period: 2014-12-08

PHARMATHENE, INCPIP

SVP & CFO

Transactions

Award
Stock options (right to buy)
2014-12-08+186,207→ 186,207 total
Exercise: $1.71Exp: 2024-12-08→ Common Stock (186,207 underlying)

Footnotes (2)

[F1]The options vest over a 4-year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
[F2]On December 8, 2014, the date the stock options were granted, the NYSE MKT closing price for the Issuer's common stock was $1.71 per share.

Documents

1 file

4
v396214_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PHARMATHENE, INC

CIK 0001326190

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001326190

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 9:03 PM ET
Size: 5.5 KB

View on SEC.gov